Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The GHB Trial: baclofen for GHB withdrawal
2013-005319-28Phase 4Terminated
- Sponsor
- Central and North West London NHS Foundation Trust
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of baclofen in gamma-hydroxybutyrate withdrawal syndrome and Gamma-butyrolactone withdrawal syndrome (GBLWS) (2 arms), sponsored by Central and North West London NHS Foundation Trust. Primary endpoints: Feasibility of a definitive randomized controlled trial, Withdrawal symptom severity and 2 more. Started Jul 2015; status: terminated.
02
Drugs
baclofen
03
Conditions
gamma-hydroxybutyrate withdrawal syndromeGamma-butyrolactone withdrawal syndrome (GBLWS)
Beyond the preview
Go deeper on 2013-005319-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005319-28.